AMRI acquires Excelsyn

Excelsyn has been acquired by AMRI for $19m. The Holywell, Wales-based business, which was formerly part of Great Lakes, includes kilo lab, pilot plant and large scale manufacturing capabilities. AMRI Chairman and CEO Thomas D’Ambra said, "The acquisition of Excelsyn further builds out AMRI's global continuum and will increase our ability to penetrate a market space relatively untapped to date, including customers in large pharma based in Europe."
Ian Shott, President and Chief Executive of Excelsyn, acquired the Holywell business in 2004 for a £3m package including debt.
Albany Times Union